Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2025-06-27 00:00:00 ET · period of report 2025-06-26 · accession 0001104659-25-063693 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-27 | 2025-06-26 | OBIO | Fain Eric S | Dir | S - Sale | $3.05 | -2,683 | 50.9K | -5% | -$8,183 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 per share ("Common Stock") | 2025-06-26 | S | D | 2,683 | $3.05 | 50,949 | I By the Fain Living Trust | — | — | (F1) The shares reported as disposed herein were granted on June 20, 2024 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. (F2) The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.11, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |